Rodman & Renshaw Reinstates Cell Therapeutics (CTIC) at Market Outperform

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/17/2026

1. SPY
2. EYPT
3. NVDA
4. TSLA
5. GNK
6. USO
7. AWK
8. ARGX
9. AZN
10. SPCX

February 21, 2012 2:54 PM EST
Get Alerts CTIC Hot Sheet
Price: $9.09 --0%

Rating Summary:
    10 Buy, 6 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Rodman & Renshaw reinstates coverage on Cell Therapeutics (NASDAQ: CTIC) with a Market Outperform. PT $3.00.

For an analyst ratings summary and ratings history on Cell Therapeutics click here. For more ratings news on Cell Therapeutics click here.

Shares of Cell Therapeutics closed at $1.35 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

New Coverage

Related Entities

Rodman & Renshaw